The ACR is closely monitoring today’s CDC discussion on
#COVID19
#vaccination
now that the FDA has authorized an additional dose of the Pfizer & Moderna
#mRNA
#vaccines
for certain immunocompromised individuals under the current EUA.
Our COVID-19 Vaccine Clinical Guidance Task force is also meeting Monday, August 16. We will share details as soon as we know what this means for
#rheum
patients & providers.